Physician profile
Jiten Desai
NPI 1003278037
$4,872.64
in general payments reported to CMS, 2019-2025
10 companies · $1,461 in 2025
The $1,461 reported for 2025 was more than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $24.67 · 2023: $75.00 · 2024: $3,312 · 2025: $1,461.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,989 · Food and Beverage: $1,859.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,988.78 |
| Food and Beverage | $1,859.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $4,539.13 | 2024-2025 | Axios, Exalt Model D, Overstitch Endoscopic Suturing System |
| Fujifilm Healthcare Americas Corporation | $160.00 | 2023-2024 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $35.70 | 2025 | Xifaxan |
| Abbott Laboratories | $24.67 | 2022 | |
| Exact Sciences Corporation | $20.95 | 2025 | Cologuard Collection Kit |
| Boehringer Ingelheim Pharmaceuticals, INC. | $19.72 | 2025 | Jardiance |
| Olympus America INC. | $19.23 | 2025 | Single Use Repositionable Clip |
| Radius Health, INC. | $18.81 | 2025 | |
| Abbvie INC. | $17.94 | 2025 | |
| Esperion Therapeutics, INC. | $16.49 | 2025 | Nexletol |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jiten Desai listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.